Kineticos Disruptor Fund is a new life sciences investment fund.
Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.The Fund will focus on large, unmet medical needs in oncology, neurosciences, and rare diseases. In oncology, new approaches to solid tumors and “off the shelf” allogeneic cell therapies are immediate priorities.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Jul 15, 2021 | Kineticos Disruptor Fund IB8 | $5.52M |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 14, 2021
Inceptor Bio
|
Seed | $26M | Biotechnology | Yes |
May 28, 2020
Promaxo
|
Series B | $10.97M | Health Care | Yes |